Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3434)	7/14/1999 5:26:00 PM
From: BMcV	Read Replies (1) \| Respond to of 10280

>>It's a slow, educative process - a doctor might try it for a few patients, and then, if impressed by the results, gradually switch existing/new patients over to it. These days, word-of-internet is increasingly important, but here again remember we are still only in the nebulizer format, where what the doctors think is more important than what the patients think.<< True enough--and it's actually even worse. There is a considerable degree of antipathy regarding "improved" medicines, which many doctors tend to view as marketing gimmicks. vide, The Medical Letter dismissal.